Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan I Epstein

Showing results (341-350 of 635) with videos related to

Pageof 64
Sort By:
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 2, 2016
Active Surveillance of Prostate Cancer: Use, Outcomes, Imaging, and Diagnostic ToolsJeffrey J Tosoian, Stacy Loeb, Jonathan I Epstein, et al.
Annals of Diagnostic Pathology|August 5, 2015
Telomerase reverse transcriptase promoter mutations in glandular lesions of the urinary bladderEric Vail, Xiaoyong Zheng, Ming Zhou, et al.
The American Journal of Surgical Pathology|June 27, 2018
Prostatic Adenocarcinoma With Focal Pleomorphic Giant Cell Features: A Series of 30 CasesAbdullah M Alharbi, Angelo M De Marzo, Jessica L Hicks, et al.
Human Pathology|December 21, 2017
Whole-exome sequencing demonstrates recurrent somatic copy number alterations and sporadic mutations in specialized stromal tumors of the prostateChin-Chen Pan, Toyonori Tsuzuki, Eiichi Morii, et al.
American Journal of Clinical Pathology|July 18, 2015
Correlation of High Body Mass Index With More Advanced Localized Prostate Cancer at Radical Prostatectomy Is Not Reflected in PSA Level and PSA Density but Is Seen in PSA MassOleksandr N Kryvenko, Jonathan I Epstein, Frederick A Meier, et al.
The Journal of Urology|September 25, 2013
Prostate specific antigen velocity risk count predicts biopsy reclassification for men with very low risk prostate cancerHiten D Patel, Zhaoyong Feng, Patricia Landis, et al.
BJU International|March 30, 2011
Repeat prostate biopsies predict location of index cancer in an active surveillance cohortKenneth S Tseng, Patricia Landis, Fadi Brimo, et al.
Journal of Computer Assisted Tomography|November 26, 2013
Multiparametric magnetic resonance imaging characterization of prostate lesions in the active surveillance population: incremental value of magnetic resonance imaging for prediction of disease reclassificationDavid Bonekamp, Susanne Bonekamp, Jeffrey K Mullins, et al.
The Journal of Urology|April 22, 2008
Residual tumor potentially left behind after local ablation therapy in prostate adenocarcinomaGhil Suk Yoon, Wenle Wang, Adeboye O Osunkoya, et al.
The Prostate|January 23, 2003
Lesions missed on prostate biopsies in cases sent in for consultationJoseph D Kronz, Rolando Milord, Robb Wilentz, et al.
Pageof 64

Showing results (341-350 of 635) with videos related to

Sort By:
Pageof 64
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 2, 2016
Active Surveillance of Prostate Cancer: Use, Outcomes, Imaging, and Diagnostic ToolsJeffrey J Tosoian, Stacy Loeb, Jonathan I Epstein, et al.
Annals of Diagnostic Pathology|August 5, 2015
Telomerase reverse transcriptase promoter mutations in glandular lesions of the urinary bladderEric Vail, Xiaoyong Zheng, Ming Zhou, et al.
The American Journal of Surgical Pathology|June 27, 2018
Prostatic Adenocarcinoma With Focal Pleomorphic Giant Cell Features: A Series of 30 CasesAbdullah M Alharbi, Angelo M De Marzo, Jessica L Hicks, et al.
Human Pathology|December 21, 2017
Whole-exome sequencing demonstrates recurrent somatic copy number alterations and sporadic mutations in specialized stromal tumors of the prostateChin-Chen Pan, Toyonori Tsuzuki, Eiichi Morii, et al.
American Journal of Clinical Pathology|July 18, 2015
Correlation of High Body Mass Index With More Advanced Localized Prostate Cancer at Radical Prostatectomy Is Not Reflected in PSA Level and PSA Density but Is Seen in PSA MassOleksandr N Kryvenko, Jonathan I Epstein, Frederick A Meier, et al.
The Journal of Urology|September 25, 2013
Prostate specific antigen velocity risk count predicts biopsy reclassification for men with very low risk prostate cancerHiten D Patel, Zhaoyong Feng, Patricia Landis, et al.
BJU International|March 30, 2011
Repeat prostate biopsies predict location of index cancer in an active surveillance cohortKenneth S Tseng, Patricia Landis, Fadi Brimo, et al.
Journal of Computer Assisted Tomography|November 26, 2013
Multiparametric magnetic resonance imaging characterization of prostate lesions in the active surveillance population: incremental value of magnetic resonance imaging for prediction of disease reclassificationDavid Bonekamp, Susanne Bonekamp, Jeffrey K Mullins, et al.
The Journal of Urology|April 22, 2008
Residual tumor potentially left behind after local ablation therapy in prostate adenocarcinomaGhil Suk Yoon, Wenle Wang, Adeboye O Osunkoya, et al.
The Prostate|January 23, 2003
Lesions missed on prostate biopsies in cases sent in for consultationJoseph D Kronz, Rolando Milord, Robb Wilentz, et al.
Pageof 64